India Pesticides Limited Holds 41st AGM: Approves Financials, Dividend, Director Re-appointments & Remuneration
India Pesticides Limited's 41st AGM on August 31, 2026, saw approval of FY26 financial statements, a final dividend for FY25-26, and re-appointment of Dr. Kuruba Adeppa. Remuneration increases for Dr. Adeppa and Dr. Udaya Bhaskar Mantripragada were also approved, alongside ratification of Cost Auditors' remuneration for FY26-27.
The AGM resolutions primarily concern routine corporate governance and director remuneration, which are important for operational continuity but do not represent a significant strategic shift or immediate financial impact on the company's core business.
All resolutions, including financial statement adoption, dividend declaration, director re-appointments, and remuneration adjustments, were passed with a significant majority, indicating strong shareholder confidence and support.
India Pesticides Limited (IPL) announced the voting results of its 41st Annual General Meeting (AGM), which was held on August 31, 2026, through video conferencing. The meeting saw overwhelming support for all resolutions.
The shareholders approved the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2026, along with the Board and Auditors' reports. A final dividend for the Financial Year 2025-26 was also declared.
Key personnel decisions included the re-appointment of Dr. Kuruba Adeppa (DIN: 08987462) as a Whole-Time Director, who was retiring by rotation. The shareholders also approved the increase in remuneration for Dr. Kuruba Adeppa and Dr. Udaya Bhaskar Mantripragada (DIN: 11169608), both Whole-Time Directors.
Furthermore, the remuneration of the Cost Auditors for the Financial Year 2026-27 was ratified. The voting results, along with the Scrutinizer's Report, indicated strong shareholder confidence, with all resolutions passing with a very high percentage of votes in favour.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.